Cargando…

Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients with Visceral Leishmaniasis

BACKGROUND: Visceral leishmaniasis (VL) is characterized by parasite-specific immunosuppression besides an intense pro-inflammatory response. Lipopolisaccharide (LPS) has been implicated in the immune activation of T-cell deficient diseases such as HIV/AIDS and idiopathic lymphocytopenia. The source...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos-Oliveira, Joanna R., Regis, Eduardo G., Leal, Cássia R. B., Cunha, Rivaldo V., Bozza, Patrícia T., Da-Cruz, Alda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134430/ https://www.ncbi.nlm.nih.gov/pubmed/21765960 http://dx.doi.org/10.1371/journal.pntd.0001198

Ejemplares similares

Lipopolysaccharide-Induced Cellular Activation May Participate in the Immunopathogenesis of Visceral Leishmaniasis Alone or in HIV Coinfection
por: Santos-Oliveira, Joanna Reis, et al.
Publicado: (2012)

Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
por: Cummings, Hannah E., et al.
Publicado: (2010)

Lower levels of leptin are associated with severity parameters in visceral leishmaniasis patients
por: Fievez, Aline Mireille da Cunha, et al.
Publicado: (2019)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis
por: Costa-Pereira, Christiane, et al.
Publicado: (2015)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Growth Factor and Th2 Cytokine Signaling Pathways Converge at STAT6 to Promote Arginase Expression in Progressive Experimental Visceral Leishmaniasis
por: Osorio, E. Yaneth, et al.
Publicado: (2014)

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS
por: ROSSI, Claudio Nazaretian, et al.
Publicado: (2016)

Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections
por: van den Bogaart, Erika, et al.
Publicado: (2014)

The reemergence of visceral leishmaniasis in Brazil.
por: Arias, J R, et al.
Publicado: (1996)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
por: Andrade-Neto, Valter Viana, et al.
Publicado: (2021)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2018)

Etoricoxib may inhibit cytokine storm to treat COVID-19
por: Wang, Ruo
Publicado: (2021)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
por: Costa, Carlos H. N., et al.
Publicado: (2023)

Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
por: García-Castro, Ana, et al.
Publicado: (2022)

Comorbid infections induce progression of visceral leishmaniasis
por: Toepp, Angela J., et al.
Publicado: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
por: Singh, Om Prakash, et al.
Publicado: (2012)

Visceral Leishmaniasis Treatment, Italy
por: Gradoni, Luigi, et al.
Publicado: (2003)

Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010)

Is visceral leishmaniasis a sepsis or not?
por: Puca, E, et al.
Publicado: (2012)

Epidemiology of Visceral Leishmaniasis in Georgia
por: Babuadze, Giorgi, et al.
Publicado: (2014)

Therapeutic Options for Visceral Leishmaniasis
por: Monge-Maillo, Begoña, et al.
Publicado: (2013)

Visceral leishmaniasis with Roth spots
por: Meena, Jagdish, et al.
Publicado: (2014)

Epidemiology of visceral leishmaniasis in Georgia
por: Kokaia, Nora, et al.
Publicado: (2017)

The kinetoplast in the diagnosis of visceral leishmaniasis
por: Murray, Henry W.
Publicado: (2022)

Cytokine storms in infectious diseases
por: Teijaro, John R.
Publicado: (2017)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019)

Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients
por: Silva-Freitas, Maria Luciana, et al.
Publicado: (2016)

Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
por: Collin, Nicolas, et al.
Publicado: (2009)

Immune Regulation during Chronic Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2014)

Pro-Cellular Exhaustion Markers are Associated with Splenic Microarchitecture Disorganization and Parasite Load in Dogs with Visceral Leishmaniasis
por: de Souza, Tainã Luís, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ti4krvofldq8n7cpf29n3ic5u